ICD-10-CM Code Updates for FY 2027
The FY 2027 ICD-10-CM update adds 190 new diagnosis codes and revises 4 existing code descriptions, effective October 1, 2026. The update brings the tabular list to 74,879 codes. This page breaks the release down chapter by chapter and lists every changed code, with a filter to find the ones that matter to you.
- Injury & poisoning (S00–T88)41,187 · 55%
- External causes (V01–Y99)7,461 · 10%
- Musculoskeletal system (M00–M99)6,687 · 8.9%
- Eye & adnexa (H00–H59)2,677 · 3.6%
- Pregnancy & childbirth (O00-O9A)2,481 · 3.3%
- Neoplasms (C00–D49)1,730 · 2.3%
- Circulatory system (I00–I99)1,433 · 1.9%
- All other chapters (15)11,223 · 15%
Hover over a slice for the full chapter name and exact counts. Totals include non-billable header categories.
Where the New Codes Landed
New codes are never spread evenly across the classification. Each release concentrates on the clinical areas where CMS and NCHS accepted proposals for greater specificity, and FY 2027 is no exception: the top two chapters account for 55% of all additions.
Chapters with no new codes in this release are omitted. Counts from the official FY 2027 addenda.
The table below covers every chapter in the classification, including the ones this release left untouched.
Total Codes is the complete FY 2027 tabular count for each chapter as loaded in the ICD List database, including non-billable header categories. New and Revised counts come from the official release addenda.
What Changed: the Big Themes
The chapters below saw the most movement in the FY 2027 release. Counts and example codes come straight from the official release files.
Injury & poisoning (S00–T88)
This chapter received 60 of the 190 new diagnosis codes in the release, 32% of all additions. New codes include T52.811A (Toxic effect of alkenes, accidental (unintentional), init), T52.811D (Toxic effect of alkenes, accidental (unintentional), subs), and T52.811S (Toxic effect of alkenes, accidental (unintentional), sequela).
Every injury-chapter addition this year is a toxic effect code. Four substances get their own subcategories: alkenes (T52.81-) and cycloparaffins (T52.82-), which replace the single other organic solvents subcategory T52.8X- (its 12 codes are deleted; other organic solvents moves to T52.89-), hexamethylene diisocyanate (T59.82-), and the sedative medetomidine (T65.85-). Each substance carries the four intents (accidental, intentional self-harm, assault, undetermined) times the initial encounter, subsequent encounter and sequela 7th characters, which is why one new substance adds 12 codes. The medetomidine codes carry a Use Additional Code note for manifestations such as bradycardia (R00.1) and somnolence, stupor and coma (R40.-). The chapter also loses the three S23.420- codes for sprain of the sternoclavicular joint under the thorax category; sternoclavicular sprains are reported with S43.61 and the rest of S43.6-.
Pregnancy & childbirth (O00-O9A)
This chapter received 44 of the 190 new diagnosis codes in the release, 23% of all additions. New codes include O00.121 (Right interstit ectopic pregnancy without uterin pregnancy), O00.122 (Left interstit ectopic pregnancy without uterin pregnancy), and O00.129 (Unsp interstit ectopic pregnancy without uterin pregnancy).
Ectopic pregnancy is now coded by implantation site. New codes cover interstitial (O00.121 through O00.139), cesarean scar (O00.31, O00.32), cervical (O00.41, O00.42) and cornual (O00.511 through O00.529) pregnancies, each split by whether an intrauterine pregnancy is also present, and by side for interstitial and cornual sites. The other 28 codes create subcategory O31.4, continuing pregnancy after vanishing twin syndrome of one fetus or more, with the trimester in the 5th character and the affected fetus in the 7th, starting at O31.40X0.
Musculoskeletal system (M00–M99)
This chapter received 31 of the 190 new diagnosis codes in the release, 16% of all additions. New codes include M04.3 (VEXAS syndrome), M67.A01 (Plantar fasciitis, right foot), and M67.A02 (Plantar fasciitis, left foot).
Most of the musculoskeletal additions give other osteomyelitis laterality. The site codes M86.8X1 through M86.8X8 are now subcategories with right, left and unspecified codes (skull, face and sinuses, and other site for M86.8X8), so a code such as M86.8X1 is no longer billable on its own; start at M86.8X11. Plantar fasciitis gets its own subcategory, M67.A01 through M67.A09, plantar fascial fibromatosis is split by foot (M72.20 through M72.22), and M04.3 adds VEXAS syndrome to the autoinflammatory syndromes.
Health status factors (Z00–Z99)
This chapter received 16 of the 190 new diagnosis codes in the release, 8% of all additions. New codes include Z68.18 (Body mass index [BMI] 18.4 or less, adult), Z68.19 (Body mass index [BMI] 18.5-19.9, adult), and Z77.013 (Contact with and (suspected) exposure to gadolinium). It also carries 1 of the 4 revised code descriptions.
The Z-code additions capture exposures that matter in veterans' care: burn pits in a war theater (Z77.32), Agent Orange (Z77.33) and blast overpressure at unspecified, low, high and other levels (Z77.40 through Z77.49), plus gadolinium exposure (Z77.013), which pairs with the new abnormal blood gadolinium finding R78.72. Personal history of sex reassignment (Z87.890) is replaced by codes for social, medical and surgical gender transition, intersex surgery and unspecified transition (Z87.8901 through Z87.8909), with Z87.893 for gender detransition. Adult BMI 19.9 or less is split into 18.4 or less (Z68.18) and 18.5 to 19.9 (Z68.19), and Z86.17 adds a personal history of Clostridioides difficile infection.
Notable changes beyond the biggest chapters
Cardiology gains specificity: dilated cardiomyopathy is split into unspecified, familial-genetic and other (I42.00 through I42.09), arrhythmogenic cardiomyopathy gets I42.81, and named arrhythmias get their own codes, including catecholaminergic polymorphic ventricular tachycardia (I47.22), Brugada syndrome (I49.81) and ventricular bigeminy (I49.82). A new category, QA1, covers genetic disorders associated with neoplasms, with codes for Lynch syndrome (QA1.71), familial cancer syndromes with pathogenic BRCA1 and BRCA2 mutations (QA1.790, QA1.791) and Li-Fraumeni syndrome (QA1.792), and Loeys-Dietz syndrome gets Q87.A.
Other single additions include odontogenic sinusitis by sinus (J34.830 through J34.839), pulmonary mycetoma (J4B), hypertrophic pyloric stenosis in childhood (K31.B), intestinal failure-associated liver disease (K76.83), post bariatric hypoglycemia (E89.830), Glanzmann thrombasthenia (D69.11), and secondary malignant neoplasms of the larynx, pharynx and oral cavity (C78.31, C78.32, C79.83). Four codes were revised: the carbuncle, cellulitis and acute lymphangitis of back codes (L02.232, L03.312, L03.322) now exclude the flank as well as the buttock, alongside the new L02.237 for carbuncle of flank, and Z29.14 was retitled.
ICD-10-CM is no longer strictly annual. CMS and NCHS can issue a mid-year update each April 1 with additional codes and tabular addenda. ICD List loads April updates into the same code set, so the counts on this page always reflect the current official files.
All 224 FY 2027 Code Changes
Every changed code in the FY 2027 release is listed below, grouped by change type and chapter, and each code links to its detail page. Type a code or keyword in the filter to narrow the lists; sections with matches expand automatically.
New codes (190)
Injury, poisoning and certain other consequences of external causes (S00–T88)60 new
| Code | Description |
|---|---|
| T52.811A | Toxic effect of alkenes, accidental (unintentional), init |
| T52.811D | Toxic effect of alkenes, accidental (unintentional), subs |
| T52.811S | Toxic effect of alkenes, accidental (unintentional), sequela |
| T52.812A | Toxic effect of alkenes, self-harm, initial encounter |
| T52.812D | Toxic effect of alkenes, self-harm, subsequent encounter |
| T52.812S | Toxic effect of alkenes, intentional self-harm, sequela |
| T52.813A | Toxic effect of alkenes, assault, initial encounter |
| T52.813D | Toxic effect of alkenes, assault, subsequent encounter |
| T52.813S | Toxic effect of alkenes, assault, sequela |
| T52.814A | Toxic effect of alkenes, undetermined, initial encounter |
| T52.814D | Toxic effect of alkenes, undetermined, subsequent encounter |
| T52.814S | Toxic effect of alkenes, undetermined, sequela |
| T52.821A | Toxic effect of cycloparaffins, accidental, init |
| T52.821D | Toxic effect of cycloparaffins, accidental, subs |
| T52.821S | Toxic effect of cycloparaffins, accidental, sequela |
| T52.822A | Toxic effect of cycloparaffins, self-harm, initial encounter |
| T52.822D | Toxic effect of cycloparaffins, self-harm, subs |
| T52.822S | Toxic effect of cycloparaffins, self-harm, sequela |
| T52.823A | Toxic effect of cycloparaffins, assault, initial encounter |
| T52.823D | Toxic effect of cycloparaffins, assault, subs |
| T52.823S | Toxic effect of cycloparaffins, assault, sequela |
| T52.824A | Toxic effect of cycloparaffins, undetermined, init |
| T52.824D | Toxic effect of cycloparaffins, undetermined, subs |
| T52.824S | Toxic effect of cycloparaffins, undetermined, sequela |
| T52.891A | Toxic effect of other organic solvents, accidental, init |
| T52.891D | Toxic effect of other organic solvents, accidental, subs |
| T52.891S | Toxic effect of other organic solvents, accidental, sequela |
| T52.892A | Toxic effect of other organic solvents, self-harm, init |
| T52.892D | Toxic effect of other organic solvents, self-harm, subs |
| T52.892S | Toxic effect of other organic solvents, self-harm, sequela |
| T52.893A | Toxic effect of other organic solvents, assault, init |
| T52.893D | Toxic effect of other organic solvents, assault, subs |
| T52.893S | Toxic effect of other organic solvents, assault, sequela |
| T52.894A | Toxic effect of other organic solvents, undetermined, init |
| T52.894D | Toxic effect of other organic solvents, undetermined, subs |
| T52.894S | Toxic effect of other organic solvents, undet, sequela |
| T59.821A | Toxic effect of hexamethylene diisocyanate, acc, init |
| T59.821D | Toxic effect of hexamethylene diisocyanate, acc, subs |
| T59.821S | Toxic effect of hexamethylene diisocyanate, acc, sequela |
| T59.822A | Toxic effect of hexamethylene diisocyanate, self-harm, init |
| T59.822D | Toxic effect of hexamethylene diisocyanate, self-harm, subs |
| T59.822S | Toxic effect of hexamethylene diisocyanate, slf-hrm, sequela |
| T59.823A | Toxic effect of hexamethylene diisocyanate, assault, init |
| T59.823D | Toxic effect of hexamethylene diisocyanate, assault, subs |
| T59.823S | Toxic effect of hexamethylene diisocyanate, assault, sequela |
| T59.824A | Toxic effect of hexamethylene diisocyanate, undet, init |
| T59.824D | Toxic effect of hexamethylene diisocyanate, undet, subs |
| T59.824S | Toxic effect of hexamethylene diisocyanate, undet, sequela |
| T65.851A | Toxic effect of medetomidine, accidental, init |
| T65.851D | Toxic effect of medetomidine, accidental, subs |
| T65.851S | Toxic effect of medetomidine, accidental, sequela |
| T65.852A | Toxic effect of medetomidine, self-harm, initial encounter |
| T65.852D | Toxic effect of medetomidine, self-harm, subs |
| T65.852S | Toxic effect of medetomidine, intentional self-harm, sequela |
| T65.853A | Toxic effect of medetomidine, assault, initial encounter |
| T65.853D | Toxic effect of medetomidine, assault, subsequent encounter |
| T65.853S | Toxic effect of medetomidine, assault, sequela |
| T65.854A | Toxic effect of medetomidine, undetermined, init |
| T65.854D | Toxic effect of medetomidine, undetermined, subs |
| T65.854S | Toxic effect of medetomidine, undetermined, sequela |
Pregnancy, childbirth and the puerperium (O00-O9A)44 new
| Code | Description |
|---|---|
| O00.121 | Right interstit ectopic pregnancy without uterin pregnancy |
| O00.122 | Left interstit ectopic pregnancy without uterin pregnancy |
| O00.129 | Unsp interstit ectopic pregnancy without uterin pregnancy |
| O00.131 | Right interstit ectopic pregnancy with uterin pregnancy |
| O00.132 | Left interstit ectopic pregnancy with intrauterine pregnancy |
| O00.139 | Unsp interstit ectopic pregnancy with uterin pregnancy |
| O00.31 | Cesarean scar ectopic pregnancy without uterin pregnancy |
| O00.32 | Cesarean scar ectopic pregnancy with intrauterine pregnancy |
| O00.41 | Cervical ectopic pregnancy without intrauterine pregnancy |
| O00.42 | Cervical ectopic pregnancy with intrauterine pregnancy |
| O00.511 | Right cornual ectopic pregnancy without uterin pregnancy |
| O00.512 | Left cornual ectopic pregnancy without uterin pregnancy |
| O00.519 | Unsp cornual ectopic pregnancy without uterin pregnancy |
| O00.521 | Right cornual ectopic pregnancy with intrauterine pregnancy |
| O00.522 | Left cornual ectopic pregnancy with intrauterine pregnancy |
| O00.529 | Unspecified cornual ectopic pregnancy with uterin pregnancy |
| O31.40X0 | Cont preg aft vanishing twin syn 1 fts or more,unsp tri,unsp |
| O31.40X1 | Cont preg aft vanishing twin syn 1 fts or more,unsp tri,fts1 |
| O31.40X2 | Cont preg aft vanishing twin syn 1 fts or more,unsp tri,fts2 |
| O31.40X3 | Cont preg aft vanishing twin syn 1 fts or more,unsp tri,fts3 |
| O31.40X4 | Cont preg aft vanishing twin syn 1 fts or more,unsp tri,fts4 |
| O31.40X5 | Cont preg aft vanishing twin syn 1 fts or more,unsp tri,fts5 |
| O31.40X9 | Cont preg aft vanishing twin syn 1 fts or more,unsp tri,oth |
| O31.41X0 | Cont preg aft vanishing twin syn 1 fts or more,1st tri,unsp |
| O31.41X1 | Cont preg aft vanishing twin syn 1 fts or more,1st tri,fts1 |
| O31.41X2 | Cont preg aft vanishing twin syn 1 fts or more,1st tri,fts2 |
| O31.41X3 | Cont preg aft vanishing twin syn 1 fts or more,1st tri,fts3 |
| O31.41X4 | Cont preg aft vanishing twin syn 1 fts or more,1st tri,fts4 |
| O31.41X5 | Cont preg aft vanishing twin syn 1 fts or more,1st tri,fts5 |
| O31.41X9 | Cont preg aft vanishing twin syn 1 fts or more, 1st tri, oth |
| O31.42X0 | Cont preg aft vanishing twin syn 1 fts or more,2nd tri,unsp |
| O31.42X1 | Cont preg aft vanishing twin syn 1 fts or more,2nd tri,fts1 |
| O31.42X2 | Cont preg aft vanishing twin syn 1 fts or more,2nd tri,fts2 |
| O31.42X3 | Cont preg aft vanishing twin syn 1 fts or more,2nd tri,fts3 |
| O31.42X4 | Cont preg aft vanishing twin syn 1 fts or more,2nd tri,fts4 |
| O31.42X5 | Cont preg aft vanishing twin syn 1 fts or more,2nd tri,fts5 |
| O31.42X9 | Cont preg aft vanishing twin syn 1 fts or more, 2nd tri, oth |
| O31.43X0 | Cont preg aft vanishing twin syn 1 fts or more,3rd tri,unsp |
| O31.43X1 | Cont preg aft vanishing twin syn 1 fts or more,3rd tri,fts1 |
| O31.43X2 | Cont preg aft vanishing twin syn 1 fts or more,3rd tri,fts2 |
| O31.43X3 | Cont preg aft vanishing twin syn 1 fts or more,3rd tri,fts3 |
| O31.43X4 | Cont preg aft vanishing twin syn 1 fts or more,3rd tri,fts4 |
| O31.43X5 | Cont preg aft vanishing twin syn 1 fts or more,3rd tri,fts5 |
| O31.43X9 | Cont preg aft vanishing twin syn 1 fts or more, 3rd tri, oth |
Diseases of the musculoskeletal system and connective tissue (M00–M99)31 new
| Code | Description |
|---|---|
| M04.3 | VEXAS syndrome |
| M67.A01 | Plantar fasciitis, right foot |
| M67.A02 | Plantar fasciitis, left foot |
| M67.A09 | Plantar fasciitis, unspecified foot |
| M72.20 | Plantar fascial fibromatosis, unspecified foot |
| M72.21 | Plantar fascial fibromatosis, right foot |
| M72.22 | Plantar fascial fibromatosis, left foot |
| M86.8X11 | Other osteomyelitis, right shoulder |
| M86.8X12 | Other osteomyelitis, left shoulder |
| M86.8X19 | Other osteomyelitis, unspecified shoulder |
| M86.8X21 | Other osteomyelitis, right upper arm |
| M86.8X22 | Other osteomyelitis, left upper arm |
| M86.8X29 | Other osteomyelitis, unspecified upper arm |
| M86.8X31 | Other osteomyelitis, right forearm |
| M86.8X32 | Other osteomyelitis, left forearm |
| M86.8X39 | Other osteomyelitis, unspecified forearm |
| M86.8X41 | Other osteomyelitis, right hand |
| M86.8X42 | Other osteomyelitis, left hand |
| M86.8X49 | Other osteomyelitis, unspecified hand |
| M86.8X51 | Other osteomyelitis, right thigh |
| M86.8X52 | Other osteomyelitis, left thigh |
| M86.8X59 | Other osteomyelitis, unspecified thigh |
| M86.8X61 | Other osteomyelitis, right lower leg |
| M86.8X62 | Other osteomyelitis, left lower leg |
| M86.8X69 | Other osteomyelitis, unspecified lower leg |
| M86.8X71 | Other osteomyelitis, right ankle and foot |
| M86.8X72 | Other osteomyelitis, left ankle and foot |
| M86.8X79 | Other osteomyelitis, unspecified ankle and foot |
| M86.8X80 | Other osteomyelitis, skull |
| M86.8X81 | Other osteomyelitis, face and sinuses |
| M86.8X89 | Other osteomyelitis, other site |
Factors influencing health status and contact with health services (Z00–Z99)16 new
| Code | Description |
|---|---|
| Z68.18 | Body mass index [BMI] 18.4 or less, adult |
| Z68.19 | Body mass index [BMI] 18.5-19.9, adult |
| Z77.013 | Contact with and (suspected) exposure to gadolinium |
| Z77.32 | Contact with and exposure to burn pits in war theater |
| Z77.33 | Contact with and (suspected) exposure to Agent Orange |
| Z77.40 | Contact with and exposure to unspecified blast overpressure |
| Z77.41 | Contact with and exposure to low-level blast overpressure |
| Z77.42 | Contact with and exposure to high-level blast overpressure |
| Z77.49 | Contact with and exposure to other blast overpressure |
| Z86.17 | Personal history of Clostridioides difficile infection |
| Z87.8901 | Personal history of social gender transition |
| Z87.8902 | Personal history of medical gender transition |
| Z87.8903 | Personal history of surgical gender transition |
| Z87.8904 | Personal history of intersex surgery |
| Z87.8909 | Personal history of unspecified gender transition |
| Z87.893 | Personal history of gender detransition |
Diseases of the circulatory system (I00–I99)9 new
| Code | Description |
|---|---|
| I42.00 | Dilated cardiomyopathy, unspecified |
| I42.01 | Familial-genetic dilated cardiomyopathy |
| I42.09 | Other dilated cardiomyopathy |
| I42.81 | Arrhythmogenic cardiomyopathy |
| I42.89 | Other cardiomyopathies not elsewhere classified |
| I47.22 | Catecholaminergic polymorphic ventricular tachycardia [CPVT] |
| I49.81 | Brugada syndrome |
| I49.82 | Ventricular bigeminy |
| I49.89 | Other specified cardiac arrhythmias not elsewhere classified |
Congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)6 new
Diseases of the digestive system (K00–K95)6 new
Diseases of the respiratory system (J00–J99)6 new
Neoplasms (C00–D49)3 new
Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50–D89)2 new
Diseases of the genitourinary system (N00–N99)2 new
Endocrine, nutritional and metabolic diseases (E00–E89)2 new
Diseases of the skin and subcutaneous tissue (L00–L99)1 new
| Code | Description |
|---|---|
| L02.237 | Carbuncle of flank |
Mental and behavioural disorders (F01–F99)1 new
| Code | Description |
|---|---|
| F64.A | Gender identity disorder, in remission |
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00–R99)1 new
| Code | Description |
|---|---|
| R78.72 | Abnormal gadolinium level in blood |
Revised codes (4)
Diseases of the skin and subcutaneous tissue (L00–L99)3 revised
Factors influencing health status and contact with health services (Z00–Z99)1 revised
| Code | Description |
|---|---|
| Z29.14 | Encounter for prophylactic rabies immune globulin |
Deleted codes (30)
Injury, poisoning and certain other consequences of external causes (S00–T88)15 deleted
| Code | Description |
|---|---|
| S23.420A | Sprain of sternoclavicular (joint) (ligament), init encntr |
| S23.420D | Sprain of sternoclavicular (joint) (ligament), subs encntr |
| S23.420S | Sprain of sternoclavicular (joint) (ligament), sequela |
| T52.8X1A | Toxic effect of organic solvents, accidental, init |
| T52.8X1D | Toxic effect of organic solvents, accidental, subs |
| T52.8X1S | Toxic effect of organic solvents, accidental, sequela |
| T52.8X2A | Toxic effect of organic solvents, self-harm, init |
| T52.8X2D | Toxic effect of organic solvents, self-harm, subs |
| T52.8X2S | Toxic effect of organic solvents, self-harm, sequela |
| T52.8X3A | Toxic effect of other organic solvents, assault, init encntr |
| T52.8X3D | Toxic effect of other organic solvents, assault, subs encntr |
| T52.8X3S | Toxic effect of other organic solvents, assault, sequela |
| T52.8X4A | Toxic effect of oth organic solvents, undetermined, init |
| T52.8X4D | Toxic effect of oth organic solvents, undetermined, subs |
| T52.8X4S | Toxic effect of oth organic solvents, undetermined, sequela |
Diseases of the musculoskeletal system and connective tissue (M00–M99)9 deleted
| Code | Description |
|---|---|
| M72.2 | Plantar fascial fibromatosis |
| M86.8X1 | Other osteomyelitis, shoulder |
| M86.8X2 | Other osteomyelitis, upper arm |
| M86.8X3 | Other osteomyelitis, forearm |
| M86.8X4 | Other osteomyelitis, hand |
| M86.8X5 | Other osteomyelitis, thigh |
| M86.8X6 | Other osteomyelitis, lower leg |
| M86.8X7 | Other osteomyelitis, ankle and foot |
| M86.8X8 | Other osteomyelitis, other site |
Diseases of the circulatory system (I00–I99)3 deleted
Factors influencing health status and contact with health services (Z00–Z99)2 deleted
Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50–D89)1 deleted
| Code | Description |
|---|---|
| D69.1 | Qualitative platelet defects |
How FY 2027 Compares to Past Years
The code set grows a little almost every year. The chart covers every annual release in the ICD List archive; hover over a bar for the exact totals, the effective window, and the change counts where available.
Each bar is the complete tabular code count for that release. The green bar is the current FY 2027 release. Because the tabular list includes non-billable header categories, the year-over-year change can differ from the count of new billable codes in the same release.
Complete year-by-year totals are also on our About page.
FY 2027 Update FAQ
When do the FY 2027 ICD-10-CM codes take effect?
The FY 2027 code set applies to dates of service from October 1, 2026 – September 30, 2027. ICD-10-CM follows the federal fiscal year, so each annual update takes effect on October 1, not January 1. Claims are coded with the code set that was valid on the date of service.
How many codes changed in the FY 2027 update?
The FY 2027 release adds 190 new diagnosis codes and revises the descriptions of 4 existing codes, bringing the tabular list to 74,879 codes. A small number of codes were also deleted or expanded into more specific options.
Can I still bill a deleted code?
Only for dates of service before the deletion took effect. From October 1, 2026 forward, claims that use a deleted code will be rejected, so any deleted code in your favorites, encounter forms, or EHR shortcuts needs to be remapped to its replacement.
Can ICD-10-CM codes change in the middle of the fiscal year?
Yes. In addition to the main October 1 release, CMS and NCHS can publish an April 1 update with new codes and tabular addenda. April updates are usually small, but they are official and billable from April 1, so it is worth rechecking high-volume codes twice a year.
Where does this data come from?
All counts and code lists on this page are loaded directly from the official FY 2027 ICD-10-CM release files published by CMS and the National Center for Health Statistics (NCHS). ICD List republishes those files without editorial changes to the underlying codes.
Sources
- Centers for Medicare & Medicaid Services, FY 2027 ICD-10-CM release files and addenda.
- National Center for Health Statistics, ICD-10-CM Official Guidelines for Coding and Reporting, FY 2027.